Skip to main content

Axim Biotechnologies, Inc.

AXIM
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0001514946

No open-market purchases or sales by Axim Biotechnologies, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Q1 2023 vs. Q4 2022

How the institutions holding Axim Biotechnologies, Inc. changed between Q4 2022 and Q1 2023.

All holders in Q1 2023All holders in Q4 2022

13F holders of AXIM: Q4 2022 compared with Q1 2023
MeasureQ4 2022Q1 2023Change
Holders10−1
Shares5000−500 (−100.0%)
Value$0$0$0

New holders (0)

Institutions that held Axim Biotechnologies, Inc. at the end of Q1 2023 but not at the end of Q4 2022.

None.

Sold out (1)

Institutions that held Axim Biotechnologies, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.

Institutions that sold out of AXIM in Q1 2023
InstitutionShares, Q4 2022Value, Q4 2022
Massmutual Trust Co FSB500$0